Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Baylor Genetics | RCV001331634 | SCV001523717 | uncertain significance | Neurodevelopmental disorder with impaired speech and hyperkinetic movements | 2020-05-06 | criteria provided, single submitter | clinical testing | This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868]. |
Ambry Genetics | RCV003284209 | SCV003961844 | uncertain significance | Inborn genetic diseases | 2023-04-21 | criteria provided, single submitter | clinical testing | May escape nonsense-mediated mRNA decay and/or be rescued by re-initiation Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
OMIM | RCV001331634 | SCV004030238 | pathogenic | Neurodevelopmental disorder with impaired speech and hyperkinetic movements | 2023-08-25 | no assertion criteria provided | literature only |